Zacks: Analysts Expect Innospec Inc. (NASDAQ:IOSP) Will Post Earnings of $1.12 Per Share

Wall Street analysts forecast that Innospec Inc. (NASDAQ:IOSP) will post earnings of $1.12 per share for the current quarter, according to Zacks. Zero analysts have issued estimates for Innospec’s earnings. Innospec posted earnings per share of $1.00 in the same quarter last year, which would indicate a positive year over year growth rate of 12%. The business is expected to report its next quarterly earnings report after the market closes on Tuesday, August 6th.

On average, analysts expect that Innospec will report full year earnings of $5.15 per share for the current financial year. For the next financial year, analysts expect that the company will report earnings of $5.35 per share. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side research analysts that follow Innospec.

Innospec (NASDAQ:IOSP) last posted its quarterly earnings data on Tuesday, May 7th. The specialty chemicals company reported $1.25 EPS for the quarter, topping analysts’ consensus estimates of $1.18 by $0.07. The company had revenue of $388.30 million for the quarter. Innospec had a return on equity of 14.92% and a net margin of 6.08%. Innospec’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.02 EPS.

A number of equities analysts have commented on IOSP shares. Zacks Investment Research raised Vistra Energy from a “hold” rating to a “buy” rating and set a $25.00 price objective on the stock in a research note on Saturday, July 13th. ValuEngine upgraded Zogenix from a “buy” rating to a “strong-buy” rating in a research report on Thursday, June 27th. Finally, BidaskClub upgraded Westport Fuel Systems from a “hold” rating to a “buy” rating in a research report on Friday, July 12th.

In other news, VP Catherine Hessner sold 2,000 shares of the business’s stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $83.64, for a total transaction of $167,280.00. Following the completion of the sale, the vice president now owns 20,923 shares in the company, valued at $1,749,999.72. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In the last 90 days, insiders have sold 4,300 shares of company stock valued at $356,236. 1.62% of the stock is currently owned by corporate insiders.

Several hedge funds have recently added to or reduced their stakes in the company. Great West Life Assurance Co. Can boosted its stake in shares of Innospec by 3.7% in the fourth quarter. Great West Life Assurance Co. Can now owns 31,977 shares of the specialty chemicals company’s stock valued at $1,823,000 after purchasing an additional 1,147 shares during the period. Geode Capital Management LLC boosted its stake in shares of Innospec by 7.6% in the fourth quarter. Geode Capital Management LLC now owns 281,594 shares of the specialty chemicals company’s stock valued at $17,391,000 after purchasing an additional 19,803 shares during the period. Principal Financial Group Inc. boosted its stake in shares of Innospec by 3.3% in the fourth quarter. Principal Financial Group Inc. now owns 206,915 shares of the specialty chemicals company’s stock valued at $12,779,000 after purchasing an additional 6,590 shares during the period. D. E. Shaw & Co. Inc. boosted its stake in shares of Innospec by 38.3% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 29,869 shares of the specialty chemicals company’s stock valued at $1,845,000 after purchasing an additional 8,273 shares during the period. Finally, Metropolitan Life Insurance Co. NY boosted its stake in shares of Innospec by 355.8% in the fourth quarter. Metropolitan Life Insurance Co. NY now owns 7,681 shares of the specialty chemicals company’s stock valued at $474,000 after purchasing an additional 5,996 shares during the period. Institutional investors own 93.34% of the company’s stock.

Innospec stock traded down $0.30 on Thursday, reaching $91.81. The company’s stock had a trading volume of 43,485 shares, compared to its average volume of 100,516. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.45 and a current ratio of 2.28. The stock has a market capitalization of $2.27 billion, a P/E ratio of 19.01 and a beta of 1.31. The company’s fifty day moving average is $87.93. Innospec has a twelve month low of $53.07 and a twelve month high of $95.28.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels.

Featured Article: What is the cash asset ratio?

Get a free copy of the Zacks research report on Innospec (IOSP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.